Chris Cooper
Stock Analyst at J.P. Morgan
(4.15)
# 1,482
Out of 4,339 analysts
171
Total ratings
63.7%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Chris Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: PME Pro Medicus Limited | Maintained: Buy | $207.90 | $128.23 | +62.13% | 24 | May 18, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | $33.50 → $37.10 | $29.15 | +27.27% | 7 | May 4, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Hold | $280.00 → $111.00 | $96.47 | +15.06% | 10 | Apr 24, 2026 | |
| RMD ResMed | Initiated Coverage: Buy | n/a | $207.98 | - | 5 | Apr 15, 2026 | |
| ASX: NAN Nanosonics Limited | Reiterated: Sell | $3.80 → $3.00 | $3.16 | n/a | 11 | Jan 24, 2024 | |
| ASX: HLS Healius Limited | Maintained: Hold | $2.90 → $1.40 | $0.352 | n/a | 11 | Jan 24, 2024 | |
| ASX: SHL Sonic Healthcare Limited | Initiated Coverage: Hold | $29.00 → $29.70 | $18.82 | n/a | 11 | Jan 24, 2024 | |
| ASX: CSL CSL Limited | Maintained: Buy | $307.00 → $309.00 | $97.33 | n/a | 13 | Dec 4, 2023 | |
| ASX: OPT Opthea Limited | Maintained: Buy | $2.80 → $2.05 | $0.60 | n/a | 4 | Oct 15, 2023 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Upgraded: Buy | $33.07 → $29.39 | $37.70 | n/a | 8 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $54.00 → $43.00 | $37.28 | n/a | 15 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $296 | $341.26 | n/a | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $7.21 | n/a | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.40 → $3.30 | $2.00 | n/a | 13 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.30 | $2.07 | n/a | 5 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.64 | n/a | 4 | Jul 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $241 | $17.46 | n/a | 1 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €113.46 | $172.10 | n/a | 1 | Aug 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 105,284p → 112,327p | $1,133.50 | n/a | 4 | Jul 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $70 | $195.57 | n/a | 9 | Jun 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 22,984p | $81.40 | n/a | 2 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $81 | $21.58 | n/a | 1 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 111,215p | $2,580.00 | n/a | 1 | Jun 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 59,834p | $259.00 | n/a | 1 | Jun 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $30.43 | n/a | 1 | May 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $100 | $313.00 | n/a | 4 | Mar 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.3746 | n/a | 1 | Mar 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $84.41 | n/a | 1 | Feb 4, 2016 |
Pro Medicus Limited
May 18, 2026
Maintained: Buy
Price Target: $207.90
Current: $128.23
Upside: +62.13%
ResMed Inc.
May 4, 2026
Maintained: Buy
Price Target: $33.50 → $37.10
Current: $29.15
Upside: +27.27%
Cochlear Limited
Apr 24, 2026
Maintained: Hold
Price Target: $280.00 → $111.00
Current: $96.47
Upside: +15.06%
ResMed
Apr 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $207.98
Upside: -
Nanosonics Limited
Jan 24, 2024
Reiterated: Sell
Price Target: $3.80 → $3.00
Current: $3.16
Upside: n/a
Healius Limited
Jan 24, 2024
Maintained: Hold
Price Target: $2.90 → $1.40
Current: $0.352
Upside: n/a
Sonic Healthcare Limited
Jan 24, 2024
Initiated Coverage: Hold
Price Target: $29.00 → $29.70
Current: $18.82
Upside: n/a
CSL Limited
Dec 4, 2023
Maintained: Buy
Price Target: $307.00 → $309.00
Current: $97.33
Upside: n/a
Opthea Limited
Oct 15, 2023
Maintained: Buy
Price Target: $2.80 → $2.05
Current: $0.60
Upside: n/a
Fisher & Paykel Healthcare Corporation Limited
Sep 26, 2023
Upgraded: Buy
Price Target: $33.07 → $29.39
Current: $37.70
Upside: n/a
Aug 24, 2023
Reiterated: Sell
Price Target: $54.00 → $43.00
Current: $37.28
Upside: n/a
Aug 15, 2023
Maintained: Hold
Price Target: $296
Current: $341.26
Upside: n/a
Apr 28, 2023
Maintained: Sell
Price Target: n/a
Current: $7.21
Upside: n/a
Mar 21, 2023
Maintained: Hold
Price Target: $3.40 → $3.30
Current: $2.00
Upside: n/a
Feb 17, 2023
Maintained: Buy
Price Target: $3.30
Current: $2.07
Upside: n/a
Jul 17, 2021
Maintained: Hold
Price Target: n/a
Current: $13.64
Upside: n/a
Mar 24, 2020
Maintained: Buy
Price Target: $241
Current: $17.46
Upside: n/a
Aug 9, 2017
Maintained: Buy
Price Target: €113.46
Current: $172.10
Upside: n/a
Jul 28, 2017
Reiterated: Buy
Price Target: 105,284p → 112,327p
Current: $1,133.50
Upside: n/a
Jun 26, 2017
Downgraded: Hold
Price Target: $70
Current: $195.57
Upside: n/a
Aug 5, 2016
Reiterated: Buy
Price Target: 22,984p
Current: $81.40
Upside: n/a
Jul 8, 2016
Upgraded: Hold
Price Target: $81
Current: $21.58
Upside: n/a
Jun 9, 2016
Reiterated: Buy
Price Target: 111,215p
Current: $2,580.00
Upside: n/a
Jun 9, 2016
Reiterated: Buy
Price Target: 59,834p
Current: $259.00
Upside: n/a
May 9, 2016
Upgraded: Buy
Price Target: n/a
Current: $30.43
Upside: n/a
Mar 7, 2016
Reiterated: Hold
Price Target: $100
Current: $313.00
Upside: n/a
Mar 3, 2016
Reiterated: Buy
Price Target: $11
Current: $0.3746
Upside: n/a
Feb 4, 2016
Reiterated: Buy
Price Target: $125
Current: $84.41
Upside: n/a